Nyheter/rapporter

Senaste pressmeddelanden och rapporter för bevakat bolag.

Datum Källa Rubrik Typ Alternativ
2022-07-22 Medicover Medicover: Delårsrapport april-juni 2022 Rapporter Ladda ner | Visa Stäng
2022-07-22 Medicover Medicover: Interim report April-June 2022 Rapporter Ladda ner | Visa Stäng
2022-07-13 Medicover Inbjudan till presentation av Medicovers rapport för andra kvartalet 2022 Pressreleaser Ladda ner | Visa Stäng
2022-07-13 Medicover Invitation to Medicover's results presentation for Q2 2022 Pressreleaser Ladda ner | Visa Stäng
2022-06-02 Medicover Medicover förvärvar MeinDentist i Tyskland Pressreleaser Ladda ner | Visa Stäng
2022-06-02 Medicover Medicover acquire MeinDentist in Germany Pressreleaser Ladda ner | Visa Stäng
2022-05-02 Medicover Medicover: Healthcare Services fortsätter att investera för framtida tillväxt Pressreleaser Ladda ner | Visa Stäng
2022-05-02 Medicover Medicover: Healthcare Services continue to invest for future growth Pressreleaser Ladda ner | Visa Stäng
2022-04-29 Medicover Antal aktier och röster i Medicover Pressreleaser Ladda ner | Visa Stäng
2022-04-29 Medicover Number of shares and votes in Medicover Pressreleaser Ladda ner | Visa Stäng
2022-04-27 Medicover Kommuniké från årsstämma i Medicover AB (publ) Pressreleaser Ladda ner | Visa Stäng
2022-04-27 Medicover Bulletin from annual general meeting in Medicover AB (publ) Pressreleaser Ladda ner | Visa Stäng
Pressreleaser | 27 Apr 2022 | Medicover

Bulletin from annual general meeting in Medicover AB (publ)

Election of the board of directors and auditor

The AGM resolved, in accordance with the proposal from the nomination committee, that the number of board members appointed by the shareholders’ meeting shall be ten. Fredrik Stenmo, Peder af Jochnick, Robert af Jochnick, Arno Bohn, Sonali Chandmal, Michael Flemming, Margareta Nordenvall and Fredrik Rågmark were re-elected, whereas Anne Berner and Azita Shariati were elected, as board members. Fredrik Stenmo was re-elected as the chairman of the board. The AGM resolved that the number of auditors shall be one without deputies and to re-elect BDO Sweden AB as the company’s auditor, with Jörgen Lövgren as auditor in charge, which is in accordance with the audit committee’s recommendation.

Fees to board members and auditor

The AGM resolved that the fees to the board members shall be paid out in a total amount of EUR 581,350, divided so that the chairman of the board of directors shall receive EUR 74,000 and the other board members who are not employed by the group shall receive EUR 53,000 each, the chairman of the audit committee shall receive EUR 23,000 and each other member of the audit committee who is not employed by the group shall receive EUR 11,250 each, the chairman of the remuneration committee shall receive EUR 8,200 and each other member of the remuneration committee who is not employed by the group shall receive EUR 8,200 each, as well as EUR 5,100 for the chairman of the sustainability committee and EUR 5,100 for each other member of the sustainability committee who is not employed by the group. It was resolved that the auditor’s fees shall be paid as per approved account.

Adoption of the annual accounts, allocation of the results and discharge from liability

The AGM resolved to adopt the annual accounts for the company and the group for 2021. In accordance with the proposal from the board of directors, the AGM determined that dividend of EUR 0.12 per share shall be paid for 2021 and record date for dividend is Friday 29 April 2022. Euroclear Sweden AB is expected to disburse dividend on Friday 6 May 2022. The last day for trading in the company’s share including right to dividend is Wednesday 27 April 2022. Furthermore, the AGM resolved to discharge the board members and the CEO from liability.

Remuneration report

The AGM approved the remuneration report prepared by the board of directors.

Instructions to the nomination committee

The AGM adopted the nomination committee’s proposed instructions to the nomination committee.

Guidelines for remuneration to senior executives

The AGM adopted the board of directors’ proposed guidelines for remuneration to senior executives.

Long term performance-based share program

The AGM resolved, in accordance with the proposal from the board of directors, to adopt a long term performance-based share program for group management and other key individuals within the Medicover group, including a maximum of 93 participants. The participants in the program are required to invest in Medicover by investing in Class B shares in the company. The participants will, provided that certain conditions are met, be granted Class B shares free of charge. Further, the AGM resolved, in accordance with the proposal from the board of directors, to adopt certain hedging arrangements in order to secure the delivery of shares to the participants at the end of the program. The hedging arrangements include an authorisation for the board of directors to issue a maximum of 1,344,440 Class C shares, of which not more than 58,440 Class C shares may be issued to secure social charges, an authorisation for the board of directors to repurchase all issued Class C shares and a resolution to transfer the repurchased shares, following reclassification into Class B shares, to the participants in the program as well as in the market in order to cover the cash flow effects arising as a result of payments of social charges.

Authorisation for the board of directors to resolve to issue new shares

The AGM authorised, in accordance with the proposal from the board of directors, the board of directors to, at one or several occasions and for the period until the next annual general meeting, resolve to issue new Class B shares. The purpose is to increase the financial flexibility of the company and the acting scope of the board of directors. The authorisation allows the board of directors to resolve to increase the company’s share capital by issue of new shares at one or several occasions and for the time period until the end of the next annual general meeting, with or without deviation from the shareholders’ preferential rights and with or without provisions for contribution in kind, set-off or other conditions, to the extent that it corresponds to a dilution of not more than ten per cent of the number of shares outstanding at the time of the shareholders’ meeting’s resolution on the proposed authorisation.

Authorisation for the board of directors to resolve to repurchase own shares

The AGM authorised, in accordance with the proposal from the board of directors, the board of directors to resolve upon repurchases of own shares of class B, on one or several occasions prior to the annual general meeting 2023. The purpose of the authorisation is to promote efficient capital usage in the company and to provide flexibility as regards the company’s possibilities to distribute capital to its shareholders. Repurchase shall maximum comprise so many shares of class B that the company’s holding does not at any time exceed ten per cent of the total number of shares in the company. Repurchase may only take place on Nasdaq Stockholm and only at a price within the price range applicable at any given time, i.e. the range between the highest purchase price and the lowest selling price.

The underlying proposals to the above resolutions are published, and at the latest on 11 May 2022 also the minutes from the AGM will be published, at www.medicover.com ( https://www.medicover.com/financial-information/corporate-governance/annual-general-meeting ).

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations

+46 703 033 272
hanna.bjellquist@medicover.com

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland and Germany. In 2021, Medicover had revenue of EUR 1,377 million and more than 38,000 employees. For more information, go to www.medicover.com

2022-04-27 Medicover Medicover: Delårsrapport Januari-mars 2022 Rapporter Ladda ner | Visa Stäng
2022-04-27 Medicover Medicover: Interim Report January-March 2022 Rapporter Ladda ner | Visa Stäng
2022-04-20 Medicover Inbjudan till presentation av Medicovers rapport för första kvartalet 2022 Pressreleaser Ladda ner | Visa Stäng
2022-04-20 Medicover Invitation to Medicover's results presentation for Q1 2022 Pressreleaser Ladda ner | Visa Stäng
2022-03-28 Medicover Medicovers årsredovisning för 2021 är publicerad Rapporter Ladda ner | Visa Stäng
2022-03-28 Medicover Medicovers annual report for 2021 is published Rapporter Ladda ner | Visa Stäng
2022-03-22 Medicover Notice of annual general meeting of Medicover AB (publ) Pressreleaser Ladda ner | Visa Stäng
2022-03-22 Medicover Kallelse till årsstämma i Medicover AB (publ) Pressreleaser Ladda ner | Visa Stäng
2022-02-28 Medicover Antal aktier och röster i Medicover Pressreleaser Ladda ner | Visa Stäng
2022-02-28 Medicover Number of shares and votes in Medicover Pressreleaser Ladda ner | Visa Stäng
2022-02-11 Medicover Medicover: Bokslutskommuniké januari-december 2021 Rapporter Ladda ner | Visa Stäng
2022-02-11 Medicover Medicover: Year-end report January-December 2021 Rapporter Ladda ner | Visa Stäng
2022-02-04 Medicover Invitation to Medicover's results presentation for Q4 2021 Pressreleaser Ladda ner | Visa Stäng
2022-02-04 Medicover Inbjudan till presentation av Medicovers rapport för fjärde kvartalet 2021 Pressreleaser Ladda ner | Visa Stäng
2022-01-28 Medicover Medicover: The acquisition of CDT Medicus Group in Poland is completed Pressreleaser Ladda ner | Visa Stäng
2022-01-28 Medicover Medicover: Förvärv av CDT Medicus i Polen är slutfört Pressreleaser Ladda ner | Visa Stäng
2022-01-18 Medicover Medicover: Förvärvet av NIPD Genetics är slutfört Pressreleaser Ladda ner | Visa Stäng
2022-01-18 Medicover Medicover: The acquisition of NIPD Genetics is completed Pressreleaser Ladda ner | Visa Stäng
2021-12-30 Medicover Antal aktier och röster i Medicover Pressreleaser Ladda ner | Visa Stäng
2021-12-30 Medicover Number of shares and votes in Medicover Pressreleaser Ladda ner | Visa Stäng
2021-12-20 Medicover Medicover tar in 277 miljoner euro med schuldschein lån för socialfinansiering Pressreleaser Ladda ner | Visa Stäng
2021-12-20 Medicover Medicover raises EUR 277 million with inaugural social financing schuldschein loan Pressreleaser Ladda ner | Visa Stäng
2021-12-09 Medicover Medicover: Increased ownership in NIPD Genetics Pressreleaser Ladda ner | Visa Stäng
2021-12-09 Medicover Medicover: Ökat ägande i NIPD Genetics Pressreleaser Ladda ner | Visa Stäng
2021-11-30 Medicover Antal aktier och röster i Medicover Pressreleaser Ladda ner | Visa Stäng
2021-11-30 Medicover Number of shares and votes in Medicover Pressreleaser Ladda ner | Visa Stäng
2021-11-05 Medicover Medicover förvärvar CDT Medicus i Polen Pressreleaser Ladda ner | Visa Stäng
2021-11-05 Medicover Medicover acquires CDT Medicus Group in Poland Pressreleaser Ladda ner | Visa Stäng
2021-11-04 Finansinspektionen Finansinspektionen: Flaggningsmeddelande i Medicover AB Pressreleaser Visa Stäng
2021-11-03 Medicover Medicover: Emission och återköp av c-aktier för incitamentsprogram Pressreleaser Ladda ner | Visa Stäng
2021-11-03 Medicover Medicover: Issue and repurchase of class C shares for incentive program Pressreleaser Ladda ner | Visa Stäng
2021-11-03 Medicover Medicover: Delårsrapport juli-september 2021 Rapporter Ladda ner | Visa Stäng
2021-11-03 Medicover Medicover: Interim report July-September 2021 Rapporter Ladda ner | Visa Stäng
2021-10-27 Medicover Medicover's Q3 report 2021 and invitation to a conference call Pressreleaser Ladda ner | Visa Stäng
2021-10-27 Medicover Medicovers rapport för tredje kvartalet 2021 och inbjudan till telefonkonferens Pressreleaser Ladda ner | Visa Stäng
2021-09-14 Medicover Medicover's nomination committee for the annual general meeting 2022 Pressreleaser Ladda ner | Visa Stäng
2021-09-14 Medicover Medicovers valberedning inför årsstämman 2022 Pressreleaser Ladda ner | Visa Stäng
2021-08-16 Medicover Medicovers fertilitetsverksamhet expanderar till Norge Pressreleaser Ladda ner | Visa Stäng
2021-08-16 Medicover Medicover is expanding its fertility network into Norway Pressreleaser Ladda ner | Visa Stäng
2021-08-03 Medicover Medicover acquire SellmerDiers sperm bank in Denmark Pressreleaser Ladda ner | Visa Stäng
2021-08-03 Medicover Medicover förvärvar spermiebanken SellmerDiers i Danmark Pressreleaser Ladda ner | Visa Stäng
2021-07-23 Medicover Medicover: Interim report April-June 2021 Rapporter Ladda ner | Visa Stäng
2021-07-23 Medicover Medicover: Delårsrapport april-juni 2021 Rapporter Ladda ner | Visa Stäng
2021-07-15 Medicover Medicovers rapport för andra kvartalet 2021 och inbjudan till telefonkonferens Pressreleaser Ladda ner | Visa Stäng
2021-07-15 Medicover Medicover's Q2 report 2021 and invitation to a conference call Pressreleaser Ladda ner | Visa Stäng
2021-06-07 Medicover Medicover Hospitals drives massive vaccination campaign at Hitex, Hyderabad Pressreleaser Ladda ner | Visa Stäng
2021-06-07 Medicover Medicover Hospitals drives massive vaccination campaign at Hitex, Hyderabad Pressreleaser Ladda ner | Visa Stäng
2021-06-01 Medicover Medicover: Staffan Ternström new COO Diagnostic Services Pressreleaser Ladda ner | Visa Stäng
2021-06-01 Medicover Medicover: Staffan Ternström ny COO för Diagnostic Services Pressreleaser Ladda ner | Visa Stäng
2021-04-29 Medicover Kommuniké från årsstämma i Medicover AB (publ) Pressreleaser Ladda ner | Visa Stäng
2021-04-29 Medicover Bulletin from annual general meeting in Medicover AB (publ) Pressreleaser Ladda ner | Visa Stäng
2021-04-29 Medicover Medicover: Interim report January-March 2021 Rapporter Ladda ner | Visa Stäng
2021-04-29 Medicover Medicover: Delårsrapport januari-mars 2021 Rapporter Ladda ner | Visa Stäng
2021-04-21 Medicover Medicover's Q1 report 2021 and invitation to a conference call Pressreleaser Ladda ner | Visa Stäng
2021-04-21 Medicover Medicovers rapport för första kvartalet 2021 och inbjudan till telefonkonferens Pressreleaser Ladda ner | Visa Stäng
2021-04-13 Medicover Medicover: Uppdatering första kvartalet - tredje våg av covid-19 driver starkt resultat Pressreleaser Ladda ner | Visa Stäng
2021-04-13 Medicover Medicover: Trading update Q1 - Covid-19 third wave drives performance Pressreleaser Ladda ner | Visa Stäng
2021-03-31 Medicover Antal aktier och röster i Medicover Pressreleaser Ladda ner | Visa Stäng
2021-03-31 Medicover Number of shares and votes in Medicover Pressreleaser Ladda ner | Visa Stäng
2021-03-30 Medicover Medicovers annual report for 2020 is published Rapporter Ladda ner | Visa Stäng
2021-03-30 Medicover Medicovers årsredovisning för 2020 är publicerad Rapporter Ladda ner | Visa Stäng
2021-03-24 Medicover Notice of annual general meeting of Medicover AB (publ) Pressreleaser Ladda ner | Visa Stäng
2021-03-24 Medicover Kallelse till årsstämma i Medicover AB (publ) Pressreleaser Ladda ner | Visa Stäng
2021-02-12 Medicover Medicover: Bokslutskommuniké januari-december 2020 Rapporter Ladda ner | Visa Stäng
2021-02-12 Medicover Medicover: Year-end report January-December 2020 Rapporter Ladda ner | Visa Stäng
2021-02-05 Medicover Inbjudan till media, investerare och analytiker för presentation av Medicovers bokslutskommuniké för 2020 Pressreleaser Ladda ner | Visa Stäng
2021-02-05 Medicover Invitation to media, investor and analyst call for Medicover's Q4 and year-end report 2020 Pressreleaser Ladda ner | Visa Stäng
2021-01-29 Medicover Medicover: Diagnostic Services COO Benedikt von Braunmühl has decided to leave the company Pressreleaser Ladda ner | Visa Stäng
2021-01-29 Medicover Medicover: Benedikt von Braunmühl, COO Diagnostic Services lämnar bolaget Pressreleaser Ladda ner | Visa Stäng

Kommande händelser

3 Nov 2022 | Kvartalsrapport 2022-Q3